Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2025-12-24 @ 5:49 PM
NCT ID:
NCT01235468
Eligibility Criteria:
Inclusion Criteria:
* age \> 18 years
* hematological malignancy
* standard indication for allogeneic transplantation
* expected survival time over 12 weeks
* no related or unrelated donor
* availability of a cord blood unit of compatible placental blood cryopreserved in at least 2 different bags; one of the two units should have a cellular content at least equal to the minimum dose of 2 x 107 nucleated cells per kilogram of body weight
Exclusion Criteria:
* Eastern Cooperative Oncology Group (ECOG) performance status \>2
* Prior allogeneic transplantation
* Pregnant or nursing women
* Positive serology for hepatitis B or C
* HIV positive
* Left ventricular ejection fraction \< 50%
* DLCO \< 50%
* Psychiatric, addictive, or any disorder/disease which compromises ability to give informed consent for participation in this study
* Treatment with other investigational drugs within 4 weeks of enrolling in this protocol
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT01235468
Study Brief:
Protocol Section:
NCT01235468